Amarin Corp. (AMRN) Tops Q3 EPS by 2c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Amarin Corp. (AMRN) Tops Q3 EPS by 2c, Revenues Miss

Amarin Reports Third Quarter 2018 Financial Results and Provides Update on Operations

November 1, 2018 5:00 AM EDT

Activities Underway to Support Planned Commercial Expansion

Management to Host Conference Call at 7:30 a.m. ET Today

BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the three and nine months ended September 30, 2018, and provided an update on company operations.

Key Amarin achievements since its last quarterly report include:

R&D progress:... More